Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Finding aid

Compounds A–Z

Every compound the Institute has assessed, with its synonyms, development codes and trade names cross-referenced to the monograph.

§1A–Z index

51 compounds and 170 cross-referenced synonyms, development codes and trade names.

#5 entries

A18 entries

B8 entries

C10 entries

D9 entries

E11 entries

G15 entries

H8 entries

I6 entries

K5 entries

L19 entries

M17 entries

N12 entries

O6 entries

P11 entries

R6 entries

S17 entries

T29 entries

V3 entries

W1 entries

X1 entries

Z4 entries

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.